Skip to search formSkip to main contentSkip to account menu

advax

National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Inulin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy
2018
2018
The Safety of an Adjuvanted Autologous Cancer Vaccine Platform in Canine Cancer Patients
Canine cancer rates are similar to humans, though the therapeutic options might be limited. Inducing a patient’s own immune… 
2016
2016
Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology
ABSTRACT Respiratory syncytial virus (RSV) is a significant cause of lower respiratory tract infections resulting in… 
2015
2015
Characterisation of adjuvants for use in dromedary immunisation
Although camelids are an important domestic species with more than 25 million members, little is known about vaccine adjuvant… 
Highly Cited
2014
Highly Cited
2014
Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
ABSTRACT Subunit vaccines against anthrax based on recombinant protective antigen (PA) potentially offer more consistent and less… 
2014
2014
A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection…
2014
2014
Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.
Highly Cited
2011
Highly Cited
2011
Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.
2008
2008
Design, Construction, and Characterization of a Dual-Promoter Multigenic DNA Vaccine Directed Against an HIV-1 Subtype C/B′ Recombinant
An effective vaccine against HIV-1 is generally considered the best hope for controlling the raging AIDS pandemic. As a part of… 
2008
2008
Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C/B′
The rapid spread of HIV-1 underscores the urgent need to develop an effective vaccine. Using modified vaccinia Ankara (MVA) as a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)